Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phage-antibiotic synergy reduces Burkholderia cenocepacia population

5 Jan 2023

Abstract excerpt

BACKGROUND: Burkholderia cenocepacia is an opportunistic pathogen that can cause acute and chronic infections in patients with weakened immune systems and in patients with cystic fibrosis. B. cenocepacia is resistant to many antibiotics making treatment challenging. Consequently, there is a critical need for alternative strategies to treat B. cenocepacia infections such as using bacteriophages and/or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Cystic Fibrosis Research Advances
Share to Invertebrate Immune Response Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36600213
DOI: 10.1186/s12866-022-02738-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phage-antibiotic synergy reduces Burkholderia cenocepacia populationPMID 36600213Read ↗

From Isolation to Application: Utilising Phage‐Antibiotic Synergy in Murine Bacteremia Model to Combat Multidrug‐Resistant Enterococcus faecalisSemantic proximity Read ↗

Bacteriophage Therapeutics: A Primer for Clinicians on Phage‐Antibiotic CombinationsSemantic proximity Read ↗

Phage metagenome-assembled genomes portraying anti-ESKAPE and anti-CRISPR/Cas potential; datasets from sewage-clinical settings of Western Uganda, sub–Saharan AfricaSemantic proximity Read ↗

Large scale phage-antibiotic combination studies reveal key combinations for urinary tract infection and urosepsis treatmentsSemantic proximity Read ↗

Large scale phage-antibiotic combination studies reveal key combinations for urinary tract infection and urosepsis treatmentsSemantic proximity Read ↗

Phage–Bacteria Interactions in Potential Applications of Bacteriophage vB_EfaS-271 against Enterococcus faecalisSemantic proximity Read ↗

Isolation of a lytic bacteriophage vB_EfaS_PHB08 and its endolysin lys08 against Enterococcus faecalis biofilmSemantic proximity Read ↗

Characterization of an Enterococcus faecalis bacteriophage SFQ1 as a potential therapeutic agentSemantic proximity Read ↗

Isolation and Characterization of a Bacteriophage Infecting Pseudomonas Aeruginosa and Its Application as a Potential Decontaminating AgentSemantic proximity Read ↗

Effective Therapeutic Options for Melioidosis: Antibiotics versus Phage TherapySemantic proximity Read ↗

Temperate phage-antibiotic synergy is widespread, but varies by phage, host, and antibiotic pairingSemantic proximity Read ↗

Phage Therapy of Extensively Drug Resistant Acinetobacter baumannii Infections: Evaluating the Distribution of Phage in Human Body and the Impact on Gut MicrobiomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.